Has Michael Ries received payments from drug or device companies?

Yes. Drug and device makers reported $7,650,886 in general payments to Michael Ries across 337 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Michael Ries did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Michael Ries come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Michael Ries

Adult Reconstructive Orthopaedic Surgery · Reno, NVNPI 1508803362

Payments from drug & device makers

What this record shows

This record is dominated by royalties or licence payments: $7,107,013 of the $7,650,886 with a category attached, or 92.9%. Smith+Nephew accounts for 96.8% of it on its own, with 8 other manufacturers making up the rest. Reporting peaked in 2021 at $1,297,939 and has fallen 73.3% since, to $347,069 in 2025.

$7,650,886in general payments, 2019–2025

Across 337 payments — averaging $22,703 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

Smith+Nephew$7.4M
Encore Medical, LP$215K
Stryker$16K
Orthalign Inc$11K
Medacta USA, Inc.$212
Avanos Medical$143
plus $127 from 3 others

$152,580in research payments, 2019–2025

Across 40 payments — averaging $3814.51 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

Smith+Nephew$153K

What the payments were for

Royalty or licence$7,107,01393%
Consulting fees$74,9561%
Speaking & faculty fees$191,6093%
Travel & lodging$57,0701%
Food & beverage$5,0170%
Other$215,2213%

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
Smith+Nephew	313	$7,408,893
Encore Medical, LP	1	$215,221
Stryker	3	$15,600
Orthalign Inc	12	$10,690
Medacta USA, Inc.	3	$212
Avanos Medical	1	$143
Heraeus Medical, LLC.	1	$76
Sanara Medtech Inc.	2	$29
Johnson & Johnson	1	$21

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

Too few adult reconstructive orthopaedic surgery providers in Nevadato place this figure against a meaningful peer group, so we don't.

Other adult reconstructive orthopaedic surgery in Reno

Chad WattsReno$78K
Jackson JonesReno$37K
Shay WarrenReno$23K
Kingsley OladejiReno$21K
Sanjai ShuklaReno$21K
Timothy OmaraReno$8K
Eric BoydenReno$7K
Steven NishiyamaLas Vegas$836K
Parminder KangLas Vegas$26K
Justin LimtongLas Vegas$22K

See the full list for Nevada →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →